Key Takeaways
- DocuSign reported Q1 adjusted earnings per share of $1.09, surpassing the $1.00 forecast, while revenue reached $830.2M compared to expectations of $823.23M
- Shares declined approximately 5% in extended trading hours despite exceeding projections
- Second quarter revenue outlook with a midpoint of $867M offers minimal upside versus the $866M analyst estimate
- Full fiscal year 2027 revenue projection midpoint of $3.496B sits just marginally higher than the $3.49B consensus
- Jefferies upgraded its target price to $50 from $45 while maintaining a Hold stance
DocuSign (DOCU) surpassed analyst expectations for both earnings and revenue in its first quarter report, yet shares fell roughly 5% in after-hours trading as the company’s future outlook failed to inspire confidence among market participants.
The e-signature leader had seen its stock price rally 27% from February lows prior to the earnings release, creating elevated investor expectations.
First quarter adjusted earnings per share registered at $1.09, exceeding the consensus projection of $1.00. Total revenue reached $830.2 million, representing 9% year-over-year growth and topping the $823.23 million forecast.
GAAP net income stood at $0.40 per diluted share, improving from $0.34 during the comparable period last year. Non-GAAP gross margin experienced a modest decline to 81.5% versus 82.3% in the year-ago quarter.
Free cash flow increased to $289.4 million compared to $227.8 million in the prior-year period. DocuSign also repurchased $317.5 million in shares, representing a significant jump from $183.4 million in the same quarter last year.
Forward Outlook Offers Modest Growth Prospects
Second quarter revenue projections range between $865M and $869M, establishing a midpoint of $867M — barely exceeding the $866M analyst consensus. This marginal beat doesn’t provide the catalyst needed to drive share price appreciation.
Full fiscal year 2027 revenue guidance spanning $3.49B to $3.502B places the midpoint only slightly above the $3.49B Wall Street estimate. The projected growth rate, when excluding foreign exchange impacts, falls between 7.1% and 7.5%.
Dollar Net Retention remained steady at 102%, showing no improvement from the previous quarter — a metric that analysts continue monitoring for signs of business acceleration.
Intelligent Agreement Management Shows Growth, Yet Skepticism Persists
DocuSign’s Intelligent Agreement Management platform currently represents 12.6% of Annual Recurring Revenue, expanding from 10.8% at January’s conclusion. CEO Allan Thygesen highlighted that the first quarter attracted 40,000 customers investing in the IAM development pipeline.
Morgan Stanley recognized the competent execution but emphasized the fundamental debate remains unchanged: “IAM adoption is advancing, though financial acceleration remains constrained and the business model lacks sufficient transparency to validate a sustainable trajectory toward double-digit expansion.”
Wolfe Research shared similar concerns, noting that DNR stagnating at 102% leaves them “seeking more concrete proof that IAM can fuel a meaningful and lasting growth resurgence.”
Jefferies elevated its price target to $50 from $45 after the revenue outperformance, though maintained its Hold recommendation. The firm observed that the stock currently trades around 10x calendar year 2027 earnings — representing the lowest valuation multiple across its mid-cap research coverage.
Enterprise bookings within North America expanded at the strongest rate during the quarter, according to Jefferies
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
